FLX-787-ODT (orally disintegrating tablet)

DRUG2 trials

Sponsors

Flex Pharma, Inc.

Conditions

Charcot-Marie-Tooth DiseaseMotor Neuron Disease

Phase 2

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

TerminatedNCT03196375

Flex Pharma, Inc.Motor Neuron Disease

Start: 2017-07-28End: 2018-07-27Updated: 2018-08-29

A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.

TerminatedNCT03254199

Flex Pharma, Inc.Charcot-Marie-Tooth Disease

Start: 2017-10-16End: 2018-07-27Updated: 2018-08-29